Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

UNKNOWN 1

Study Type

Observational 1

Sponsor

Conditions

Esophageal Neoplasms 7Breast Neoplasms 6Rectal Neoplasms 4Neoplasms 4Radiation Injuries 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Hormone Receptor Positive Advanced Breast Cancer 2Brain Neoplasms 2Varicose Veins 1Syphilis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Recurrence 1Pathologic Complete Response 1Papillomavirus Infections 1Mesothelioma, Malignant 1Lymphoid Neoplasm 1Lymphocele 1Hyperparathyroidism, Primary 1Hypercalcemia 1Head and Neck Neoplasms 1HIV Infections 1HER2-positive Breast Cancer 1Cardiovascular Diseases 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Observational × Lymphoid Neoplasm × Clear all
NCT04509804 2020-08-12

Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma

ChineseAMS

Completed
26 enrolled

Lymphoid Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡